ophthalmologytimes2h
FDA grants fast track designation to N-acetylcysteine amide tablets from Nacuity Pharmaceuticals
The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...
ophthalmologytimes22h
Stuart Therapeutics completes Phase 3 trial of vezocolmitide for treatment of dry eye disease
Stuart Therapeutics completed a Phase 3 trial for ST-100, a treatment for dry eye disease, involving a randomized, ...